Research Analysts Issue Forecasts for ORIC FY2025 Earnings
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of ORIC Pharmaceuticals in a research note issued to investors on Thursday, May 29th. Cantor Fitzgerald analyst P. Agrawal expects that the company will post earnings per share of ($1.71) for the […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of ORIC Pharmaceuticals in a research note issued to investors on Thursday, May 29th. Cantor Fitzgerald analyst P. Agrawal expects that the company will post earnings per share of ($1.71) for the […]
